Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.

Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page has been updated to reflect a new version of the clinical trial information, with the revision number changing from v2.14.4 to v2.15.0 and a new date of 2025-04-09 replacing the previous date of 2024-11-05.SummaryDifference3%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check86 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check100 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference5%
- Check107 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.